RE:LABS commercialization wheels are now in full motion for subaru1i wrote: pharmaceutical API's. It is now more important to focus on all press releases/earnings reports going forward and my personal approach is when a company reaches that stage of it's development, personally there is no longer a need for me to participate in any forums.
With that said, I have already submitted my request to have my account deleted and all posts removed.
I would like to further express my gratitude for the contributors that brought forth valuable information to this board. It's been a lot of fun but the next phase for LABS is now in motion and that phase means no longer having a past time of a posting board.
Good luck to all, don't forget to take advantage of your TFSA. This stock will do extremely well and remember that anti-inflammatory drug, say targeting avian influenza inflammation of human lungs is a subset of the broader category of 'anti-virals'.
Reminder: As Pidduck stated, they were targeting Q1, 2024 as turning the corner and posting positive EPS...that will be a shockwave within the big category of cannabis stocks.
Sincerely, Athea and Ed.
Dont tease us now!!
beam him up
Il see ya when i see ya